Great Point Partners LLC Sage Therapeutics, Inc. Transaction History

Great Point Partners LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $9.97 Million - $12.7 Million	-269,010 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $765,342 - $1.09 Million	19,010 Added 7.6%	269,010 $11.9 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $7.25 Million - $10.5 Million	-132,085 Reduced 34.57%	250,000 $14.2 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $5.11 Million - $7 Million	-72,332 Reduced 15.92%	382,085 $28.6 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $88.3 Million - $135 Million	-1,512,271 Reduced 76.89%	454,417 $39.3 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $5.58 Million - $8.47 Million	-135,680 Reduced 6.45%	1,966,688 $120 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $7.21 Million - $12 Million	277,889 Added 15.23%	2,102,368 $87.4 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $26.9 Million - $79.4 Million	1,028,422 Added 129.19%	1,824,479 $52.4 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $47.9 Million - $123 Million	796,057 New	796,057 $57.5 Million
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $30.4 Million - $38.5 Million	-200,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $5.5 Million - $15.1 Million	90,500 Added 82.65%	200,000 $32.9 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $6.72 Million - $9.69 Million	109,500	109,500 $6.82 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.